O’Donnell, John C. http://orcid.org/0000-0001-8101-3783
Purvis, Erin M.
Helm, Kaila V. T.
Adewole, Dayo O.
Zhang, Qunzhou
Le, Anh D.
Cullen, D. Kacy http://orcid.org/0000-0002-5355-5216
Funding for this research was provided by:
National Science Foundation (DGE-1845298)
Michael J. Fox Foundation for Parkinson’s Research (Therapeutic Pipeline Program #9998)
United States Department of Defense | United States Army | Army Medical Command | Medical Research and Materiel Command (W81XWH-16-1-0796)
Center for Undergraduate Research and Fellowships at the University of Pennsylvania
Article History
Received: 17 June 2020
Accepted: 15 June 2021
First Online: 15 July 2021
Competing interests
: D.K.C. is a co-founder of two University of Pennsylvania spin-out companies concentrating in applications of neuroregenerative medicine: INNERVACE, Inc. and Axonova Medical, LLC. There are several patent applications related to the methods, composition, and use of micro-tissue engineered glial and neuronal networks, including U.S. Patent App. 15/534,934 titled “Methods of promoting nervous system regeneration” (D.K.C.), U.S. Patent App. 15/032,677 titled “Neuronal replacement and reestablishment of axonal connections” (D.K.C.), U.S. Patent App. 16/093,036 titled “Implantable living electrodes and methods for the use thereof” (D.K.C.), and U.S. Provisional Patent App. 63/197,007 titled “Tissue-engineered rostral migratory stream for neuronal replacement” (J.C.O’D., E.M.P., Q.Z., A.D.L., and D.K.C.). No other author has a potential competing interest to disclose.